# Phase 4 Diabetes Mellitus trials recruiting: 111 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 111 trials in phase 4 for Diabetes Mellitus that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 Diabetes Mellitus trials: 111 rows for $5.55, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/diabetes-mellitus

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 111
- Recruiting or not yet: 111
- Read on: November 19, 2026

## Trials

The 25 newest of 111, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07942805 | Dexamethasone Doses and Glycemic Response in Diabetic Cholecystectomy | Assiut University | Phase 4 | Not yet recruiting | Diabetes Mellitus, Hyperglycemia | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942805) |
| November 16, 2026 | NCT07939750 | Sotagliflozin Versus Empagliflozin Added to Metformin for Glycemic Control in Type 2 Diabetes | Allied Hospital Faisalabad | Phase 4 | Not yet recruiting | Type 2 Diabetes Mellitus (DM) | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939750) |
| October 23, 2026 | NCT07891234 | Effect of SGLT2 Inhibitor on Metabolic-Dysfunction-Associated Fatty Liver Disease in Patients With Insulin Resistance | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | MAFLD in Prediabetes and Diabetes | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891234) |
| October 7, 2026 | NCT07864480 | Continuous Delivery of Ranibizumab Via the Port Delivery System for Proliferative Diabetic Retinopathy-related Vitreous Hemorrhage With... | Southeast Retina Center, Georgia | Phase 4 | Not yet recruiting | Proliferative Diabetic Retinopathy, Diabetic Retinopathy, Diabetes | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864480) |
| October 1, 2026 | NCT07852988 | Pancreatin Added to Standard Antihyperglycemic Therapy in Patients With Type 2 Diabetes | Silesian Centre for Heart Diseases | Phase 4 | Recruiting | Type 2 Diabetes (T2DM) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852988) |
| September 10, 2026 | NCT07811427 | Heart-Kidney-Diabetes Multidisciplinary Care MOdels for CardiovascuLar Health In Patients With Chronic Kidney DiSease and Diabetes: A... | Baim Institute for Clinical Research | Phase 4 | Not yet recruiting | Chronic Kidney Disease, Type II Diabetes | 570 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07811427) |
| September 2, 2026 | NCT07800468 | Efficacy of Topical Lidocaine Gel vs. Oral Duloxetine for Painful Diabetic Peripheral Neuropathy | Wah Medical college , POF hospital | Phase 4 | Not yet recruiting | Painful Diabetic Neuropathy (PDN), Diabetic Neuropathies, Type 2 Diabetes | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07800468) |
| August 18, 2026 | NCT07771010 | The Effect of Empagliflozin and Metformin on Oxidative Capacity and Microvascular Reactivity of Skeletal Muscle in Patients With Type 2... | University Medical Centre Ljubljana | Phase 4 | Recruiting | Diabetes Type 2 | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07771010) |
| August 5, 2026 | NCT07747402 | Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes | Xi'an International Medical Center Hospital | Phase 4 | Not yet recruiting | Type 2 Diabetes | 462 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07747402) |
| July 31, 2026 | NCT07739537 | PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses | Massachusetts General Hospital | Phase 4 | Not yet recruiting | Diabete Type 2, Pharmacogenomic Drug Interaction | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07739537) |
| July 29, 2026 | NCT07733232 | Fecal Microbiota Transplantation for Type 2 Diabetes Mellitus and Hashimoto's Thyroiditis | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Autoimmune Thyroid Disease, Type 2 Diabetes Mellitus (T2DM), FMT | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07733232) |
| July 22, 2026 | NCT07719894 | Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes | Seoul National University Bundang Hospital | Phase 4 | Recruiting | Type 2 Diabetes Mellitus (T2DM), Atherosclerosis | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07719894) |
| July 17, 2026 | NCT07711171 | Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment | Fudan University | Phase 4 | Recruiting | Type 2 Diabetes Mellitus, Cognitive Impairment | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711171) |
| July 15, 2026 | NCT07706088 | Effect of Tirzepatide on Diabetic Peripheral Sensorimotor Neuropathy | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 | Not yet recruiting | Neuropathy, Small Fiber, Diabete Mellitus | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07706088) |
| July 15, 2026 | NCT07704190 | Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease | Peking University Third Hospital | Phase 4 | Not yet recruiting | Cardiorenal Metabolic Syndrome, Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, Coronary Artery... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704190) |
| July 13, 2026 | NCT07697391 | AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes | The First Affiliated Hospital of Anhui Medical University | Phase 4 | Recruiting | Obesity, Diabetes Mellitus, Type 2 | 285 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697391) |
| July 6, 2026 | NCT07685886 | MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes | University of Colorado, Denver | Phase 4 | Not yet recruiting | Diabetes, Kidney Disease, Vascular Disease, Retinopathy | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07685886) |
| June 25, 2026 | NCT07667517 | Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease | First Affiliated Hospital of Zhejiang University | Phase 4 | Not yet recruiting | Albuminuria, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Diseases | 148 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667517) |
| May 29, 2026 | NCT07614230 | SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes | Sponsor not shown (see the record) | Phase 4 | Recruiting | Type 2 Diabetes Mellitus (T2DM), Coronary Artery Disease, Atherosclerosis | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614230) |
| May 14, 2026 | NCT07588438 | Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay. | Las Rías Medical Center | Phase 4 | Recruiting | Obesity, Diabetes Mellitus, Type 2 | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07588438) |
| May 1, 2026 | NCT07561541 | Extended Oral Antibiotic Prophylaxis in Diabetic Fracture Patients | Texas Tech University Health Sciences Center, El Paso | Phase 4 | Recruiting | Fracture Lower Leg, Diabetes, Fracture Fixation, Internal | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07561541) |
| April 30, 2026 | NCT07558863 | Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes | The First Affiliated Hospital with Nanjing Medical University | Phase 4 | Recruiting | Type 2 Diabetes, Diabetes With Diabetic Autonomic Neuropathy (Diagnosis) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07558863) |
| April 29, 2026 | NCT07555730 | AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN) | Huazhong University of Science and Technology | Phase 4 | Not yet recruiting | Overweight or Obesity; Type 2 Diabetes, Weight Loss Maintenance | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07555730) |
| April 17, 2026 | NCT07537088 | Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic... | First Affiliated Hospital of Wannan Medical College | Phase 4 | Not yet recruiting | T2DM (Type 2 Diabetes Mellitus), CKD - Chronic Kidney Disease | 468 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07537088) |
| March 27, 2026 | NCT07494084 | Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance | Washington State University | Phase 4 | Recruiting | Shift Work Schedule, Circadian Rhythm, Insulin Resistance, Circadian Misalignment | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07494084) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Seoul National University Bundang Hospital | 7 |
| University of Colorado, Denver | 2 |
| Ohio State University | 2 |
| University Medical Centre Ljubljana | 2 |
| Korea University Anam Hospital | 2 |
| Stanford University | 2 |
| Guangzhou University of Traditional Chinese Medicine | 2 |
| Yonsei University | 2 |
| Massachusetts General Hospital | 2 |
| The First Affiliated Hospital with Nanjing Medical University | 2 |
| [Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/hangzhou-zhongmei-huadong-pharmaceutical-co-ltd) | 2 |
| Copenhagen University Hospital, Rigshospitalet | 1 |
| Federico II University | 1 |
| First Affiliated Hospital of Wannan Medical College | 1 |
| Les Laboratoires des Médicaments Stériles | 1 |
| The First Affiliated Hospital of Anhui Medical University | 1 |
| University of Michigan | 1 |
| General Hospital of Shenyang Military Region | 1 |
| Ain Shams University | 1 |
| University of Campania Luigi Vanvitelli | 1 |
| Second Affiliated Hospital of Nanchang University | 1 |
| University Medical Center, Kazakhstan | 1 |
| University of Missouri-Columbia | 1 |
| Assiut University | 1 |
| Hospital Universitario Dr. Jose E. Gonzalez | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 26 |
| United States | 25 |
| South Korea | 14 |
| Denmark | 6 |
| Italy | 3 |
| Pakistan | 3 |
| Canada | 3 |
| Egypt | 2 |
| Netherlands | 2 |
| Slovenia | 2 |
| Germany | 2 |
| Austria | 2 |
| United Kingdom | 2 |
| Tunisia | 1 |
| Kazakhstan | 1 |
| Mexico | 1 |
| Paraguay | 1 |
| Indonesia | 1 |
| Afghanistan | 1 |
| Kenya | 1 |
| Nigeria | 1 |
| Sri Lanka | 1 |
| Poland | 1 |
| Taiwan | 1 |
| Hong Kong | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Marble and granite professional companies in the United States](https://specstream.ai/data/businesses/marble-and-granite-professional-companies/united-states)
- [HR services firms in the United States](https://specstream.ai/data/businesses/hr-services-firms/united-states)
- [Financial advisory firms in the United States](https://specstream.ai/data/businesses/financial-advisory-firms/united-states)
- [Dental supply stores in the United States](https://specstream.ai/data/businesses/dental-supply-stores/united-states)
- [Cabinet makers in the United States](https://specstream.ai/data/businesses/cabinet-makers/united-states)
- [B2B cleaning and waste management companies in the United States](https://specstream.ai/data/businesses/b2b-cleaning-and-waste-management-companies/united-states)
